|
|
- Primrose Rose
- 8 years ago
- Views:
Transcription
1 A Gay Men s Health Service Audit of: Post Exposure Prophylaxis Robert Obara, BSc MPH MBBChBAO Candidate, TCD Class of 2014 Poster for BASHIV, Dr Dominic Rowley (GMHS) et al.
2 PEP Talk Antiretroviral drugs (Truvada + Kaletra) Within 72 hours of HIV exposure Must be taken for 4 weeks Free of charge Side effects often experienced GMHS PEP Audits Main audit: July 2011 October 2011 Compiled demographics Evaluated clinical management Re-audit competed spring 2013
3 PEP Recipient Demographics } 52 PEP recipients were identified 31 from the first audit & 21 from the re-audit } All were MSM }
4 Reason for requesting PEP HIV Risk 13% (n=7) documented partner as HIV positive (3 of 7 documented partner taking HAART) Majority unaware of their partners status 27% (n=14) reported condom accidents No cases of non consensual sex were documented Majority were documented as consensual unprotected intercourse with a casual partner
5 1 st Clinical Review Findings 87% (n=27) had baseline HIV bloods documented 90% (n=29) received Truvada and Kaletra 77% (n=24) completed the full course Reasons for non-completion included discovery of partner HIV status, PEP side effect intolerance, anxiety, and limited HIV exposure 77% (n=24) had a 4 week follow-up HIV test 67% (n=21) had a 12 week test All 31 patients tested HIV negative at subsequent blood tests
6 Re-Audit of Clinical Practice 100% (n=21) had baseline HIV test 95% (n=20) had Hep B immunity status documented 90% (n=19) had Hep C result within the past 2 years Decrease in PEP prescriptions for insertive anal only No seroconversions were discovered Noted inconsistencies in the timing of follow up HIV tests (1 12 weeks) and lab tests (FBCs and LFTs) Thus standardized clinical protocol and patient leaflets
7 PatientInformationLeafletonPEPSE HighRiskPack Youarebeingstartedoncombinationanti viraldrugs.thisistohelppreventhiv afterpossiblesexualexposuretothehivvirus. Thedrugsintwoseparateproducts(colouredtablets)willbeprescribedforatotalof 28Days. Youhavereceivedan8daypack.YoumustattendyournextappointmentatGMHS toobtaintherestofthesupply,beforethe8daysupplyrunsout. Pleasetrynottomissanydoses.Ifyouforgettotakeadose,takeitassoonasyou rememberandthenextdoseatthenormaltime.nevertakeadoubledose. PleasecheckwithyourdoctorattheGMHSabouttakinganynewmedications (prescriptionornonprescription)whilstonthiscombinationtherapy. ContactTelephoneNumber:GMHS DateofPrescription: Doctor: Appointments&Procedures. 1 st Appointment:(7or8daysfromtoday): RestofTabletsandBloodTests:LFT/FBC/Renal. 2 nd Appointment:6WeeksfromprescriptionDate ST Is cre ena n dbl oo d Tes t s: (HIV,HEPC,Syphilis). 3 rd Appointment:12WeeksfromprescriptionDate: FinalBloodTests:(HIV,HEPC,Syphilis). DrugsDescription TRUVADA (BlueTablet) TakeisONEtabletperDAY,withfood. TheTRUVADA tabletcontains2differentdrugs Tenofovir(Ten)andEmtricitabine (FTC).Itisusuallywelltolerated. Possiblesideeffectsincludeachesandpains,dizziness,headaches,diarrhoea, nausea,vomitingandinsomnia.(therearetabletstohelpwiththisseebelow) KALETRA (PaleYellowTablet) TakeTWOtabletsTWICEaday(every12Hours),withorwithoutfood. TheactivedruginKaletra islopinavir.asmalldoseofanadditionaldrug,ritonavir, isincludedtoincreasethebloodlevelsoflopinavir. ThemostcommonsideaffectsofKALETRA arediarrhoeaandincreasedcholesterol. Headache,insomnia,gastrointestinaleffectsandchangesinbloodsugarsorliver enzymesmayalsooccur. TherearesomemedicationsthatcannotbetakenwhenonKALETRA Itisimportanttotellthedoctorandpharmacistaboutanyothermedications (prescriptionornonprescription)youarecurrentlytaking. Helpfulhints: (BLUEtablet:onceperday) (Pale/Yellowtablet:2twiceperdaymorningandevening) OthermedicationbelowtohelpyouwhiletakingPEP Thesecanbeboughtatachemistwithoutprescription Imodium2mgCapsules Anti DiarrhoeaTabletstotakeasneededdaily Motilium10mgTablets Anti NauseaTablets Take2tablets,30minutesbeforetheothertabletsprescribed.Morningandevening forthemonthasnecessary. Paracetamol(takeasdirectedonpack) Thisisasuitablepainkillertotakeforheadache,achesorpains
8
Prevention of transmission of HIV and other bloodborne viruses in healthcare and post exposure prophylaxis. John Ferguson, UPNG 2012
Prevention of transmission of HIV and other bloodborne viruses in healthcare and post exposure prophylaxis John Ferguson, UPNG 2012 Outline Epidemiology Making the diagnosis / contact tracing Antiretroviral
More informationHPTN 073: Black MSM Open-Label PrEP Demonstration Project
HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers
More informationGetting to Know PrEP (Pre-Exposure Prophylaxis)
(Pre-Exposure Prophylaxis) What is PrEP? Prep stands for Pre-Exposure Prophylaxis: a medication that was recently approved by the FDA for daily use that can help high-risk patients who are HIV negative
More informationPOST EXPOSURE PROPHYLAXI S
Departments of Infectious Diseases & Emergency Medicine POST EXPOSURE PROPHYLAXI S QUI CK GUI DE FOR EMERGENCY DEPT Adapted from Irish National PEP Guidelines and St James s Hospital GUIDE Clinic/Emergency
More informationNON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS (npep)
NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS (npep) Guidance from the Michigan Department of Health and Human Services Division of Health, Wellness & Disease Control Revised June 2015 The Michigan Department
More information4/15/2010. Vermont Department of Health STD/HIV Program Vermont Department of Health STD/HIV Program. Vermont Department of Health STD/HIV Program
First Let s Look at Some Numbers HIV Postexposure Prophylaxis for Occupational and Non- occupational Exposure National Vermont VtSHP Annual Meeting 4/10/10 Deborah Kutzko FNP "Financial support for this
More informationPre-exposure prophylaxis (PrEP)
FACTSHEET Pre-exposure prophylaxis (PrEP) Summary Pre-exposure prophylaxis, or PrEP, is a way for an HIV-negative person who is at risk of HIV infection to reduce their risk of becoming infected with HIV.
More informationGUIDELINES FOR THE MANAGEMENT OF A PERCUTANEOUS OR SEXUAL EXPOSURE TO BLOODBORNE PATHOGENS DEPARTMENT OF HEALTH AND WELLNESS PRINCE EDWARD ISLAND
GUIDELINES FOR THE MANAGEMENT OF A PERCUTANEOUS OR SEXUAL EXPOSURE TO BLOODBORNE PATHOGENS DEPARTMENT OF HEALTH AND WELLNESS PRINCE EDWARD ISLAND Revised February 2012 TABLE OF CONTENTS INTRODUCTION AND
More informationCondoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers
Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers James Wilton Coordinator, Biomedical Science of HIV Prevention
More informationPOSTEXPOSURE PROPHYLAXIS
POSTEXPOSURE PROPHYLAXIS Bloodborne viruses Hepatitis B Hepatitis C HIV Hepatitis B Risk of seroconversion HBeAg negative 2% HBeAg positive 20-40% If seroconvert most recover completely and develop immunity
More informationFAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.
HIV & AIDS What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. What does HIV stand for? Human Immunodeficiency Virus Where did HIV
More informationHIV Guidelines. New Strategies.
HIV Guidelines. New Strategies. Santiago Moreno Hospital Universitario Ramón y Cajal Madrid HIV Guidelines. New Strategies. Outline HIV Guidelines What is new? New strategies Treatment as Prevention HIV
More informationHepatitis C. Screening, Diagnosis and Linkage to Care
Hepatitis C Screening, Diagnosis and Linkage to Care Diagnosis If your hepatitis C antibody test is reactive, a second test will be needed to diagnose and determine if you are currently infected. Screening
More informationHIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016
HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016 Daily emtricitabine/tenofovir (Truvada ) is safe and effective for reducing the risk of HIV acquisition in sexually
More informationNON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS. Carl LeBuhn, MD
NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS Carl LeBuhn, MD Post-Exposure Prophylaxis (PEP) The use of therapeutic agents to prevent infection following exposure to a pathogen
More informationPOST EXPOSURE MANAGEMENT: HEPATITIS B, HEPATITIS C AND HIV
Middlesex-London Health Unit 50 King St. London, Ontario N6H 5M3 Phone: 519-663-5317 X 2330 After Hours: 519-675-7523 Fax: 519-663-9581 www.healthunit.com POST EXPOSURE MANAGEMENT: HEPATITIS B, HEPATITIS
More informationPOST-EXPOSURE PROPHYLAXIS (HIV, HEP B, HEP C)
POST-EXPOSURE PROPHYLAXIS (HIV, HEP B, HEP C) www.hiv-druginteractions.org No major changes to this protocol since last reviewed in 2014 Reference should also be made to the NHSGGC document on management
More informationPatient Information Sheet
Healthcare Worker exposure to a patient s blood What is a healthcare worker exposure? Patient Information Sheet Occasionally, health care workers come into contact with the blood or body fluids of their
More informationTitle: Post Exposure Prophylaxis Page 1 of 8 Policy No: 1 CLN 010 Effective Date 04/15/11
Title: Post Exposure Prophylaxis Page 1 of 8 OBJECTIVE To standardize medical care following a Blood or Bodily Fluid Exposure (BBFE). SCOPE All Exposed Individuals (as defined below) who present for post-exposure
More informationHIV. Looking after your sexual health
HIV Looking after your sexual health 2 HIV HIV stands for Human Immunodeficiency Virus. Once someone is infected with HIV the virus will remain in their body for the rest of their life. There is currently
More informationFrequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013
Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013 On July 16, 2012, the Food and Drug Administration (FDA) approved
More informationGuidelines for Nurse Led HIV Clinic
Guidelines for Nurse Led HIV Clinic Produced and approved by (Committee and Date) Kieran Sharkey Ratified by (Committee and Date) Reviewed Review date: Guidelines for Nurse Led HIV Clinic Introduction
More informationHIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline
HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline Background... 2 Screening... 2 Recommendations... 2 Ordering and consent... 2 Indications for Periodic HIV Screening...
More informationJuly 3, 2015. III. VA policy:
Antiretroviral Postexposure Prophylaxis After Sexual, Injection- Drug Use, or Other Nonoccupational Exposure to HIV (nonoccupational post- exposure prophylaxis [npep]) VA Greater Los Angeles Healthcare
More informationInjection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral
More informationIncrease of sexually transmitted hepatitis C virus in HIV+ men who have sex with men in Barcelona, Spain. A problem linked to HIV infection?
Increase of sexually transmitted hepatitis C virus in HIV+ men who have sex with men in Barcelona, Spain. A problem linked to HIV infection? S. Manzanares-Laya 1, P. García de Olalla 1,2, C. Garriga 1,3,
More informationAppendix 3 Exposure Incident Report Form
Appendix 3 Exposure Incident Report Form January, 2015 Page 1 of 6 Please see the following pages for the Exposure Incident Report Form. Guidelines for the Management of Exposure to Blood and Body Fluids
More informationPost-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV. National Guidelines
Post-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV National Guidelines National guidelines for post-exposure prophylaxis after non-occupational and occupational exposure
More informationABI Consumer Guide for gay men on HIV and Life Insurance
ABI Consumer Guide for gay men on HIV and Life Insurance In October 2005, the insurance industry implemented a new Statement of Best Practice on HIV and Insurance. Produced by the Association of British
More informationProtocol for Needle Stick Injuries Occurring to NY Medical College Students In Physicians Offices
Protocol for Needle Stick Injuries Occurring to NY Medical College Students In Physicians Offices Procedures to be followed by physicians for needle stick incidents to medical students rotating through
More informationDidactic Series. Updated Post-Exposure Prophylaxis (PEP) Guidelines. Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014
Didactic Series Updated Post-Exposure Prophylaxis (PEP) Guidelines Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014 ACCREDITATION STATEMENT: University of California, San Diego School of
More informationIntegrated Post-exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids
Integrated Post-exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids MARCH 2009 COMMUNICABLE DISEASE CONTROL Integrated Post-exposure Protocol for HIV, HBV
More informationStefan R. Rowniak, PhD, RN, MS, FNP. University of California, San Francisco, CA. University of California, San Francisco, CA
Stefan R. Rowniak, PhD, RN, MS, FNP EDUCATION 2010 2010 1991 1985 1979 1976 SF State University Seattle University Seattle, WA University of Washington Seattle, WA Post-Doctoral Student PhD, Nursing MSN,
More informationBloodborne Pathogens (HIV, HBV, and HCV) Exposure Management
Bloodborne Pathogens Exposure Policy and Procedures Employees of the State of South Dakota Department of Health Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management PEP Hotline 1-888-448-4911 DOH
More informationHow testing and treatment can stop HIV. Information for gay and bisexual men.
How testing and treatment can stop HIV. Information for gay and bisexual men. How testing and treatment can stop HIV. Information for gay and bisexual men. We re living in a new era. We now know for sure:
More informationWhen an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)
XI. OCCUPATIONAL EXPOSURES TO HEPATITIS B AND C RECOMMENDATION: When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) The risk of transmission
More informationOffering HIV Post-Exposure Prophylaxis (PEP) Following Non-Occupational Exposures
Offering HIV Post-Exposure Prophylaxis (PEP) Following Non-Occupational Exposures Recommendations for Health Care Providers in the State of California Arnold Schwarzenegger Governor State of California
More informationBelgian development agency
Belgian development agency AIDS WHAT YOU SHOULD KNOW KEY PRINCIPLES Respect Respect yourself and others. Testing Do not wait until tomorrow. Adherence Adhere to treatment and enjoy a long and happy life.
More informationTOOLS, TRENDS AND NEW TECHNOLOGIES IN HIV PREVENTION
TOOLS, TRENDS AND NEW TECHNOLOGIES IN HIV PREVENTION Introduction In recent years, prevention has moved to the top of the global HIV and AIDS agenda. Michel Sidibé, Executive Director of UNAIDS, recently
More informationPostexposure Prophylaxis (PEP)
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Postexposure Prophylaxis (PEP) Hillary Liss, MD Clinical Assistant Professor of Medicine, University of Washington Medical Program Director, NW AETC Last Updated:
More informationMEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Multiple Sclerosis Agents
MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Multiple Sclerosis Agents A. Prescriptions That Require Prior Authorization Prescriptions
More informationAAB 2013 Annual Meeting & Educational Conference
American Association of Bioanalysts AAB 2013 Annual Meeting & Educational Conference Occult Hepatitis and HIV Prophylaxis Thursday, May 16, 2013, 9:45 a.m. John H. Hughes, Ph.D. Dept Molecular Virology,
More informationEstimates of New HIV Infections in the United States
Estimates of New HIV Infections in the United States Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in new HIV infections has historically
More informationInstructions for Abroad Clinical Rotation
Revised 7/12 Instructions for Abroad Clinical Rotation While travelling abroad you may have limited access to medical care. These instructions help prepare you for a blood/ body fluid exposure. Timely
More informationNon-Academic Program Assessment Form Assessment Cycle: 2010-2011
College/Division Head: P.Rault, Ph.D Goal 1. Student Health Services (SHS) will support students in their growth and development. Objective 1.1. Provide quality primary care to students in a medical facility
More informationUWHC GME Global Health Emergency Plan
UWHC GME Global Health Emergency Plan Purpose: The purpose of the Global Health Emergency Plan is to identify the appropriate procedure in the event that an emergency occurs involving a resident participating
More informationGuidelines for Blood borne Pathogen Exposure and Post Exposure Prophylaxis at Global Health Field Sites
Guidelines for Blood borne Pathogen Exposure and Post Exposure Prophylaxis at Global Health Field Sites Developed by Dr. Brian Jack and colleagues at Boston University Adapted with permission by Dr. Chad
More informationNeedle-Stick Policy. http://www.utdallas.edu/ehs
Needle-Stick Policy Department of Environmental Health and Safety 800 West Campbell Rd., SG10 Richardson, TX 75080-3021 Phone 972-883-2381/4111 Fax 972-883-6115 http://www.utdallas.edu/ehs Modified: May
More informationSPECIALTY PROVIDER MANUAL
New York State Department of Health AIDS INSTITUTE Uninsured Care Programs Pre- Exposure Prophylaxis Assistance Program (PrEP-AP) SPECIALTY PROVIDER MANUAL 518-459-1641 EMPIRE STATION P.O. BOX 2052 ALBANY,
More informationHIV-Associated Risk Behaviour Among Drug Users at Drug Rehabilitation Centres
, ORIGINAL ARTICLE HIV-Associated Risk Behaviour Among Drug Users at Drug Rehabilitation Centres M N Fauziah, MD, S Anita, MD, B N Sha'ari, MD, B I RosH, MD Introduction HIV infection and AlDS is a major
More informationPEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationQ and A for PARTNER Studies: Interim analysis results presented at CROI 2014. CROI presentation can be found at www.chip.dk
Q and A for PARTNER Studies: Interim analysis results presented at CROI 2014 STATUS: Results embargoed until 4 March 2014, 18:30 Central European Time (CET). CROI presentation can be found at www.chip.dk
More informationCondoms for the prevention of HIV and STI transmission
FACTSHEET Condoms for the prevention of HIV and STI transmission Summary Condoms are physical barriers that can reduce the risk of a sexual exposure to HIV and sexually transmitted infections (STIs). They
More informationHIV/AIDS: General Information & Testing in the Emergency Department
What Is HIV? HIV/AIDS: General Information & Testing in the Emergency Department HIV is the common name for the Human Immunodeficiency Virus. HIV is a retrovirus. This means it can enter the body s own
More informationHIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014
To protect, promote and improve the health of all people in Florida through integrated state, county, and community efforts. HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida,
More informationTranscending Barriers for Safer Pleasure
March 2016 PrEP Pre-Exposure Prophylaxis Transcending Barriers for Safer Pleasure a publication for transgender women Table of contents 1 2 5 6 7 8 9 10 10 11 12 13 14 15 16 17 18 19 20 Using this booklet...
More informationUNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE
UNAIDS 214 LESOTHO HIV EPIDEMIC PROFILE 214 LESOTHO Overview The Kingdom of Lesotho is landlocked and surrounded by South Africa. It has a surface area of 3 355 square kilometres and its population is
More informationHepatitis A/B Vaccination of inmates in the Los Angeles County Jail
Hepatitis A/B Vaccination of inmates in the Los Angeles County Jail Garrett Cox, MPH Epidemiologist, Infection Control & Epidemiology Los Angeles County Sheriff s Department Information about LASD Jail
More informationModule 7: The Role of the Nurse
Module 7: The Role of the Nurse Module Objectives To describe the dynamic role of the nurse in the holistic care of a patient receiving ARV treatment To equip nurses with a sense of importance and belief
More informationWISCONSIN AIDS/HIV PROGRAM NOTES
Wisconsin 2014 HIV Care Continuum: Statewide and Select Population Groups Casey Schumann, MS, AIDS/HIV Program Epidemiologist, AIDS/HIV Program, Wisconsin Division of Public Health Background The HIV care
More informationUK Guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure (PEPSE)
UK Guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure (PEPSE) 0 0 0 Guideline working group: Martin Fisher Chair of writing group, late Professor of HIV medicine at Brighton
More informationPost-Exposure Prophylaxis (PEP) Guidelines for children and adolescents potentially exposed to blood-borne viruses
Post-Exposure Prophylaxis (PEP) Guidelines for children and adolescents potentially exposed to blood-borne viruses Authors: C Foster, G Tudor-Williams, A Bamford Date reviewed: June 2015 Next review date:
More informationTherapeutic Guidelines. Accidental exposure guidelines
Therapeutic Guidelines Accidental exposure guidelines As of February 2009 Management of Accidental Exposure to HIV Counseling should be offered to all persons experiencing an exposure event. If there is
More information(C) Deep injury and those caused by hollow bore needles, where more potential transference of blood is involved.
PROLOGUE The use of ARVs for post exposure prophylaxis following occupational exposure to HIV has raised different areas of uncertainty for policy makers and healthcare workers. The Ministry of Health
More informationInstructions for Clinical Rotation Abroad
[Type text] Revised 6/13 Instructions for Clinical Rotation Abroad While travelling abroad you may have limited access to medical care. These instructions help prepare you for a blood/ body fluid exposure.
More informationClinical Infectious Diseases Advance Access published September 1, 2015
Clinical Infectious Diseases Advance Access published September 1, 2015 1 No New HIV Infections with Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting Jonathan E. Volk 1, Julia
More informationUNIVERSITY OF KENTUCKY HEALTH CARE COLLEGES POLICY ON EDUCATIONAL EXPOSURE TO BLOOD BORNE PATHOGENS
I. Purpose and Definition UNIVERSITY OF KENTUCKY HEALTH CARE COLLEGES POLICY ON EDUCATIONAL EXPOSURE TO BLOOD BORNE PATHOGENS The purpose of this policy is to delineate the management of incidents of exposure
More informationHIV, Hepatitis B, Hepatitis C and Sexually Transmitted Infections
Alberta Guidelines for Non-Occupational, Occupational and Mandatory Testing and Disclosure Act Post-Exposure Management and Prophylaxis: HIV, Hepatitis B, Hepatitis C and Sexually Transmitted Infections
More information04/06/2015. Aaron V. Sapp, MD, MBA University of Missouri Columbia Student Health Center
Aaron V. Sapp, MD, MBA University of Missouri Columbia Student Health Center 1 Men Women 20.6% Talked to doctor 18.2% Talked to doctor 79.4% Did not talk to doctor 81.8% Did not talk to doctor Lack of
More informationGuidelines for Viral Hepatitis CTR Services
Guidelines for Viral Hepatitis CTR Services During the 2007 North Dakota Legislative Assembly, legislation that called for the creation of a viral hepatitis program was introduced and approved. The North
More informationPOST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING
MARCH 2014 A Quick Guide to POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING HIV PROVIDER REFERENCE SERIES A PUBLICATION OF THE MOUNTAIN PLAINS AIDS EDUCATION AND TRAINING CENTER MountainPlains AIDS
More informationThe Basics of Drug Resistance:
CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu The Basics of Drug Resistance: QUESTIONS AND ANSWERS HIV Drug Resistance and ARV-Based Prevention 1. What is drug resistance?
More information12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS
HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE DISEASE 101 ONLINE CONFERENCE SARAH WENINGER, MPH VIRAL HEPATITIS.STD.HIV PREVENTION COORDINATOR DECEMBER 3, 2015 OBJECTIVES Describe the populations that should
More informationNew York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy
New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy Policy Statement The accelerated four-dose schedule for combined hepatitis A and B vaccine
More informationHow To Improve Health Care For An Hiv Patient
The Role of the Nurse Practitioner in HIV Care The Three Bridges Shared Care Model Goals of the HIV Shared Care Program To improve access to primary HIV care for difficult to reach populations To demonstrate
More informationAntiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States
Recommendations and Reports January 21, 2005 / 54(RR02);1-20 Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States Recommendations
More informationCore Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session.
Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* ABOUT THIS ACTIVITY Time: 60 minutes Objectives: By the end of this session, participants will be able to: Reviewed their knowledge of HIV/AIDS
More informationCRISP1 Data Archive. The NIDDK Repository offers the following three data packages from the CRISP1 study:
CRISP1 Data Archive The NIDDK Repository offers the following three data packages from the CRISP1 study: 1. The standard data archive, which contains a dataset compiled by the Data Center, Center for Research
More informationGuidelines for. Blood-borne Pathogen Exposure and Post-Exposure Prophylaxis in Global Health Field Sites
UW Global Health Institute Guidelines for Blood-borne Pathogen Exposure and Post-Exposure Prophylaxis in Global Health Field Sites Developed by Dr. Brian Jack and colleagues at Boston University Adapted
More informationHIV Prophylaxis For Adults After Sexual Assault. Recommendations for Health Care Providers
HIV Prophylaxis For Adults After Sexual Assault Recommendations for Health Care Providers Developed by: Oregon Attorney General s Sexual Assault Task Force and Oregon Health Authority HIV Prevention Program
More informationProblems and Measures Regarding Waste 1 Management and 3R Era of public health improvement Situation subsequent to the Meiji Restoration
More information
OHIO ATTORNEY GENERAL SEXUAL ASSAULT FORENSIC EXAMINATION (SAFE) PROGRAM INSTRUCTIONS FOR REIMBURSEMENT FORM
OHIO ATTORNEY GENERAL SEXUAL ASSAULT FORENSIC EXAMINATION (SAFE) PROGRAM INSTRUCTIONS FOR REIMBURSEMENT FORM All exams must be conducted using the 2011 Ohio Sexual Assault Protocol for Sexual Assault Forensic
More informationHIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK
HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf
More informationThe Epidemiology of Internet Sex Partnering and Intervention Use, California
The Epidemiology of Internet Sex Partnering and Intervention Use, California Jeffrey D. Klausner, MD, MPH Director, STD Prevention and Control Services San Francisco Department of Public Health Associate
More informationA publication for men who have sex with men. Is taking PrEP the right choice for you? your life matters
A publication for men who have sex with men Pre-exposure Prophylaxis Is taking PrEP the right choice for you? your life matters MAY 2015 Check out our four videos on PrEP as well! an overview of PrEP how
More informationBLOOD AND BODY FLUID EXPOSURE MANAGEMENT TOOL
655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2400 Fax 604.707.2401 www.bccdc.ca Clinical Prevention Services Tel 604.707.5600 Fax 604.707.5604 www.smartsexresource.com BLOOD AND BODY FLUID EXPOSURE
More informationFrequently Asked Questions (FAQs)
Frequently Asked Questions (FAQs) Research Rationale 1. What does PrEP stand for? There is scientific evidence that antiretroviral (anti-hiv) medications may be able to play an important role in reducing
More informationUnderstanding the HIV Care Continuum
Understanding the HIV Care Continuum Overview Recent scientific advances have shown that antiretroviral therapy (ART) not only preserves the health of people living with HIV, but also dramatically lowers
More informationUnited States Department of Justice. Best Practices Guide to Reform HIV Specific Criminal Laws to Align with Scientifically Supported Factors
U.S. Department of Justice Civil Rights Division United States Department of Justice Civil Rights Division Best Practices Guide to Reform HIV Specific Criminal Laws to Align with Scientifically Supported
More informationHIV futures six Making Positive Women s Lives Count
archsf HIV futures six Making Positive Women s Lives Count Rachel Koelmeyer Karalyn McDonald Marian Pitts Jeffrey Grierson ABOUT THE SURVEY The HIV Futures research program is the largest of its kind in
More informationQuick Guide. For Clinicians. Based on TIP 37 Substance Abuse Treatment For Persons With HIV/AIDS
Quick Guide For Clinicians Based on TIP 37 Substance Abuse Treatment For Persons With HIV/AIDS Contents Why a Quick Guide?................ 2 What Is a TIP?.................... 3 Introduction......................
More informationSHARPS INJURY POLICY
INFECTION PREVENTION AND CONTROL SHARPS INJURY POLICY MANAGEMENT OF EXPOSURE TO BLOOD BORNE VIRUSES HIV POST EXPOSURE PROPHYLAXIS Read in conjunction with: Policy for safe handling and disposal of sharps
More informationAssertive outreach enhances hepatitis B vaccination for people who inject drugs in Melbourne, Australia
Assertive outreach enhances hepatitis B vaccination for people who inject drugs in Melbourne, Australia Peter Higgs, Nyree Chung, Shelley Cogger, Rebecca Winter, Margaret Hellard & Paul Dietze Acknowledgements
More informationThe Role of New Media on Sexual Health
The Sexual Health of Gay Men and Other MSM: HIV/STD Prevention Plus Conference The Fenway Institute, Boston MA April 26-27, 2010 The Role of New Media on Sexual Health David S. Novak, MSW, CAS Senior Public
More informationBASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC
BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC HIV What are HIV and AIDS? HIV stands for Human Immunodeficiency Virus. This is the virus that causes AIDS. HIV is
More informationChlamydia THE FACTS. How do people get Chlamydia?
What is Chlamydia? Chlamydia is a common bacterial infection that is sexually transmitted and often causes no symptoms. If not treated, chlamydia can damage reproductive organs and make it difficult for
More informationUNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS Country Progress Report 2008 Sweden ABBREVIATIONS...3 ACKNOWLEDGEMENTS...4 STATUS AT A GLANCE...1 NATIONAL INDICATOR DATA... 2 OVERVIEW OF THE
More informationBurton Hospitals NHS Foundation Trust. Corporate / Directorate. Clinical / Non Clinical. Department Responsible for Review:
POLICY DOCUMENT Burton Hospitals NHS Foundation Trust Approved by: INOCULATION / SHARPS INJURY POLICY Clinical Management Board On: 13 February 2014 Review Date: January 2017 Corporate / Directorate Clinical
More information